RTSN 8-K 2026-10-13

Retension Pharmaceuticals, Inc. (RTSN) 8-K dated 2026-10-13 — accession 0001213900-26-109024.

Retension Pharmaceuticals, Inc. (RTSN) common stock.

Retension Pharmaceuticals, Inc. filed a 8-K on 2026-10-13. Accession 0001213900-26-109024.

This 8-K covers: Bylaws or fiscal year change (Item 5.03), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for RTSN is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The RTSN SEC hub lists recent forms. The stock page is the research view.